drugset / Trial / NCT06803030
Study of Tamsulosin, Solifenacin and Mirabegron in Alleviating Ureteral Stent-related Symptoms
RandomizedParallel-groupSingle-blindTreatment
Summary
A comparative study on the efficacy of Tamsulosin, Solifenacin and Mirabegron in alleviating ureteral stent-related symptoms: a randomized controlled trial.
Timeline
- Start
- 2025-08-30
- Primary completion
- 2025-12-01
- Completion
- 2026-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Mirabegron | Other / unclassified | 25 mg | — |
| Comparator | Solifenacin | Small molecule | 5 mg | — |
| Comparator | Tamsulosin | Other / unclassified | 0.4 mg | — |
Indications
No indication recorded.